134 related articles for article (PubMed ID: 38491809)
1. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study.
Rashidi-Ranjbar N; Churchill NW; Black SE; Kumar S; Tartaglia MC; Freedman M; Lang A; Steeves TDL; Swartz RH; Saposnik G; Sahlas D; McLaughlin P; Symons S; Strother S; Pollock BG; Rajji TK; Ozzoude M; Tan B; Arnott SR; Bartha R; Borrie M; Masellis M; Pasternak SH; Frank A; Seitz D; Ismail Z; Tang-Wai DF; Casaubon LK; Mandzia J; Jog M; Scott CJM; Dowlatshahi D; Hassan A; Grimes D; Marras C; Zamyadi M; Munoz DG; Ramirez J; Berezuk C; Holmes M; Fischer CE; Schweizer TA
Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6074. PubMed ID: 38491809
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
3. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
[TBL] [Abstract][Full Text] [Related]
4. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
5. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
El Haffaf LM; Ronat L; Cannizzaro A; Hanganu A;
J Alzheimers Dis; 2024; 97(2):841-853. PubMed ID: 38143342
[TBL] [Abstract][Full Text] [Related]
6. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
[TBL] [Abstract][Full Text] [Related]
7. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.
Ozzoude M; Varriano B; Beaton D; Ramirez J; Adamo S; Holmes MF; Scott CJM; Gao F; Sunderland KM; McLaughlin P; Goubran M; Kwan D; Roberts A; Bartha R; Symons S; Tan B; Swartz RH; Abrahao A; Saposnik G; Masellis M; Lang AE; Marras C; Zinman L; Shoesmith C; Borrie M; Fischer CE; Frank A; Freedman M; Montero-Odasso M; Kumar S; Pasternak S; Strother SC; Pollock BG; Rajji TK; Seitz D; Tang-Wai DF; Turnbull J; Dowlatshahi D; Hassan A; Casaubon L; Mandzia J; Sahlas D; Breen DP; Grimes D; Jog M; Steeves TDL; Arnott SR; Black SE; Finger E; Rabin J; ; Tartaglia MC
Alzheimers Res Ther; 2023 Jun; 15(1):114. PubMed ID: 37340319
[TBL] [Abstract][Full Text] [Related]
9. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
10. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
[TBL] [Abstract][Full Text] [Related]
16. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
Anor CJ; Dadar M; Collins DL; Tartaglia MC
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
[TBL] [Abstract][Full Text] [Related]
19. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
20. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
